Wisconsin NCI Community Oncology Research Program (WiNCORP)

威斯康星州 NCI 社区肿瘤​​学研究计划 (WiNCORP)

• 批准号: 10225431
• 负责人: Natasha Edwin
• 金额: $ 280.28万
• 依托单位: MARSHFIELD CLINIC RESEARCH FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10225431
• 关键词: Academic Medical Centers; Advisory Committees; Aftercare; Agreement; American College of Radiology Imaging Network; American College of Surgeons Oncology Group; Area; Basic Science; Cancer Burden; Cancer Center; Caring; Clinic; Clinical Research; Clinical Trials; Clinical Trials Network; Collaborations; Communication; Community Clinical Oncology Program; Community Outreach; Conduct Clinical Trials; County; Development; Eastern Cooperative Oncology Group; Education; Elderly; Foxes; Geography; Goals; Grant; Health Service Area; Health Services Accessibility; Health system; Healthcare Systems; Hospitals; Human Resources; Image; Individual; Infrastructure; Institution; Integrated Health Care Systems; Iowa; Leadership; Low income; Michigan; Minnesota; Mission; Molecular Target; North Central Cancer Treatment Group; Oncology; Operative Surgical Procedures; Patient Care; Patients; Pattern; Phase; Physicians; Positioning Attribute; Prevention; Procedures; Process; Provider; Publications; Quality of life; Recording of previous events; Research; Research Infrastructure; Research Personnel; Research Project Grants; Resource Sharing; Rural; Rural Population; Screening for cancer; Site; Symptoms; System; Systems Development; Translational Research; Underrepresented Populations; Wisconsin; Work; base; cancer care; cancer clinical trial; cancer health disparity; cancer prevention; care delivery; community engagement; disparity reduction; feasibility trial; improved; member; multidisciplinary; participant enrollment; patient population; programs; research study; rural area; screening; service programs; survivorship; symptom management; synergism

PROJECT SUMMARY The Wisconsin NCORP (WiNCORP) is a consortium of three established healthcare systems in the state of Wisconsin with a long-standing history of excellence in oncology care – Marshfield Clinic Health System, Gundersen Health System, and ThedaCare. Through a network of hospitals, clinics, and other facilities spanning most of the state of Wisconsin, upper Michigan and adjacent counties in Northern Iowa and Southeastern Minnesota, WiNCORP institutions collectively provide care and access to oncology clinical trials to a predominantly rural population. Member sites participate in numerous NCI-sponsored clinical trials and are active in NCORP research base committees, NCI task forces and steering committees, research networks, and organizations with a focus on improving cancer care. Investigators from each system are consistently recognized by the NCI and/or the research bases for their accrual totals, and WiNCORP has been designated as a high-performing site over the previous grant cycle. Through the work of multidisciplinary care teams and research staff, WiNCORP will continue to leverage its collective expertise to open numerous cancer care delivery research (CCDR) trials. With a shared mission to provide patient access to NCI-sponsored clinical trials, WiNCORP members are well-positioned to increase patient accruals from historically underrepresented populations in clinical trials such as rural, elderly, and low-income individuals, enhance cancer care delivery, and reduce disparities in cancer burden across the region. To achieve this goal, WiNCORP leadership has outlined four specific aims for the consortium: 1) Conduct NCI Phase I/II, II and III cancer screening, prevention, symptom management, treatment, post-treatment, imaging and quality of life trials across the entire WiNCORP service area. 2) Facilitate conduct of Cancer Care Delivery Research (CCDR) across our integrated health care systems through establishment of an expanded research infrastructure. 3) Facilitate accrual to molecular target driven trials. 4) Incorporate a new patient population and provider group in the WiNCORP consortium that currently has no access to CCDR studies. These specific aims will be accomplished by expanding communication channels between patients and WiNCORP members, streamlining the process of site opening for various clinical trials, enhancing resource sharing among member sites, enhancing community engagement in clinical trial participation, and continual enhancements and developments in infrastructure and personnel to open and accrue patients to a variety of clinical trial types. It is anticipated that WiNCORP-wide efforts in staff education, clinical trial feasibility assessment, harmonized internal processes, synchronized regulatory support, development of system and trial-specific standard operating procedures, and collaboration among investigators from the three consortium sites will create a synergy that will further enhance clinical trial conduct, efficiency, and quality.

项目概要 威斯康星州 NCORP (WiNCORP) 是由威斯康星州三个已建立的医疗保健系统组成的联盟 在肿瘤治疗方面拥有悠久的卓越历史——Marshfield Clinic Health System、Gundersen Health System 和 ThedaCare 通过覆盖威斯康星州大部分地区的医院、诊所和其他设施网络。 密歇根州以及爱荷华州北部和明尼苏达州东南部的邻近县，WiNCORP 机构统称 为主要参与的农村人口提供护理和获得肿瘤临床试验的机会。 进行了大量 NCI 资助的临床试验，并积极参与 NCORP 研究基地委员会、NCI 工作组和指导工作 委员会、研究网络和组织，重点关注改善癌症护理。 系统的应计总数始终得到 NCI 和/或研究基地的认可，并且 WiNCORP 已被 通过多学科护理团队的工作，在上一个资助周期中被指定为高绩效场所。 WiNCORP 将继续利用其集体专业知识来开放众多癌症护理服务 WiNCORP 的共同使命是为患者提供参与 NCI 赞助的临床试验的机会。 成员处于有利地位，可以增加临床试验中历史上代表性不足的人群的患者应计人数 例如农村、老年人和低收入人群，加强癌症护理服务，并减少癌症负担的差异 为了实现这一目标，WiNCORP 领导层为该联盟制定了四个具体目标：1) 进行 NCI I/II、II 和 III 期癌症筛查、预防、症状管理、治疗、治疗后、 整个 WiNCORP 服务领域的成像和生活质量试验 2) 促进癌症护理服务的开展。 通过建立扩大的研究，在我们的综合医疗保健系统中进行研究（CCDR） 3) 促进分子靶标驱动试验的积累。 4) 纳入新的患者群体。 WiNCORP 联盟中目前无法访问 CCDR 研究的提供商团体将实现这些具体目标。 通过扩大患者和 WiNCORP 成员之间的沟通渠道、简化 各类临床试验站点开放流程，加强会员站点之间的资源共享，增强 社区参与临床试验以及基础设施的不断增强和发展 预计 WiNCORP 范围内的努力将开放并吸引患者参加各种临床试验类型。 在员工教育、临床试验可行性评估、协调的内部流程、同步的监管支持、 系统和试验特定标准操作程序的开发，以及研究人员之间的协作 这三个联盟站点将产生协同作用，进一步提高临床试验的实施、效率和质量。